Innovative intervention for pregnant and breastfeeding adolescent mothers to enhance viral suppression in Homa Bay County, Kenya - Elizabeth Okoth (presented by N. Rakhmanina), MPH

International Workshop on HIV & Women 2019

High PrEP uptake among HIV-exposed women with pregnancy plans in South Africa - Lynn Matthews, MD

International Workshop on HIV & Women 2019

Non-Vaccine Oncogenic HPV Persistence Among HPV-Vaccinated Women Living with HIV - Elisabeth McClymont

International Workshop on HIV & Women 2019

Cardiac Muscle Health Among Women Aging with HIV - Markella Zanni, MD

International Workshop on HIV & Women 2019

Dolutegravir pharmacokinetics during pregnancy and postpartum - Angela Colbers, PhD

International Workshop on HIV & Women 2019

Vaginal microbiome and associations with tenofovir diphosphate and lamivudine triphosphate in cervical tissues of Ugandan women - Melanie Nicol, PharmD, PhD

International Workshop on HIV & Women 2019

HIV Cure: Where have we been, where are we going? - Daniel Kuritzkes, MD

International Workshop on HIV & Women 2019

Invited lecture: Focus on women - Jintanat Ananworanich, MD, PhD

International Workshop on HIV & Women 2019

Abstract: HCV, HBV and HIV infection and linkage to care in migrants: The Immigrant Take Care Advocacy (I.Ta.C.A.) experience in Palermo | Marco Tutone

International Viral Hepatitis Elimination Meeting (IVHEM) 2018

Clinical Pharmacology of ARV Drugs | Mas Chaponda

Gulf HIV Clinical Forum 2018

HIV treatment failure: practical tips | Ali Elgalib

Gulf HIV Clinical Forum 2018

General lecture on HIV drug resistance | Ghassan Wali, MD, FRCP(C)

Gulf HIV Clinical Forum 2018

Abstract: Prevalence of neuropsychiatric conditions among HIV positive compared to HIV negative commercially insured individuals in 2017 NAFLD with dyslipidemia (#5) | Joshua Cohen, PhD

HIV DART and Emerging Viruses 2018

Abstract: Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in a rapid initiation model of care for HIV-1 infection: Week 24 interim analysis of the DIAMOND study (#6) | Keith Dunn, PharmD, BCPS, AAHIVE

HIV DART and Emerging Viruses 2018

Abstract: Initial viral load decline and response rates by baseline viral load strata with dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate/emtricitabine: Pooled results from the GEMINI studies (#7) | Michael Aboud

HIV DART and Emerging Viruses 2018

Hispanic/Latino longitudinal cohort of HIV-seropositive women and neurological complications | Loyda Melendez, PhD

HIV DART and Emerging Viruses 2018

Abstract: Rhesus macaque model of SIV/SHIV-Zika co-infection (#9) | Siddappa Byrareddy

HIV DART and Emerging Viruses 2018

State of the Art Lecture: Molecular basis for HIV latency | Jonathan Karn, PhD

HIV DART and Emerging Viruses 2018

Understanding barriers to HIV cure | Robert Siliciano, MD, PhD

HIV DART and Emerging Viruses 2018

Gertrude Elion Distinguished Lecturer Award Lecture: Innovation with an Impact: Development of HIV and TB drugs | Paul Stoffels, MD

HIV DART and Emerging Viruses 2018

HIV reservoir dynamics: Implications for HIV latency establishment and reversal | Deanna Kulpa, PhD

HIV DART and Emerging Viruses 2018

Baricitinib reverses HIV associated neurocognitive disorders and reservoir seeding in a SCID mouse model | Christina Gavegnano, PhD

HIV DART and Emerging Viruses 2018

State of the Art Lecture: Harnessing the immune system to eliminate and/or control HIV | Steven Deeks, MD

HIV DART and Emerging Viruses 2018

Potential for HIV cure by stem cell transplantation (IciStem) | Monique Nijhuis, PhD

HIV DART and Emerging Viruses 2018